Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT03696784 |
| Title | Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | UNC Lineberger Comprehensive Cancer Center |
| Indications |
primary mediastinal B-cell lymphoma |
| Therapies |
Bendamustine + Fludarabine + iC9-CAR.19-IL15-Transduced CB-NK |
| Age Groups: | adult | senior |
| Covered Countries | USA |
CKB BOOST